The Instructor Will Assign Ten 10 Drug Cards Per Week In Spe

The Instructor Will Assign Ten 10 Drug Cards Per Week In Speci

The instructor will assign ten (10) drug cards per week, in specific areas. Each card will be worth 1 point. You will not receive the points for the cards if they are not submitted within the week when due. Cards must be handwritten, legible, and on ruled index cards. All information required on the card must be completed or you will not receive the point for the card.

The following information must be on the drug card for each drug:

• Generic and Trade/Brand Names (American only)
• Classifications:
  • Therapeutic
  • Pharmacological
• Indications/Uses
• Contraindications
• Adverse reactions by all systems
• Safe dosage range
• 3 nursing implications
• Action

Paper For Above instruction

The process of medication management in nursing encompasses comprehensive understanding and application of pharmacology principles, including drug classification, indications, contraindications, adverse effects, dosage, nursing implications, and mechanisms of action. This task involves creating detailed drug cards for specific medications to reinforce knowledge, assist in clinical decision-making, and ensure patient safety.

As part of the course requirement, students will develop a total of ten handwritten, legible drug cards weekly. These cards serve as quick reference tools, summarizing essential medication information on ruled index cards. Given the importance of accuracy and completeness in medication administration, meticulous attention must be paid to include all required details, including generic and brand names, classifications, indications, contraindications, adverse reactions, safe dosage ranges, nursing implications, and mechanisms of action.

The first set of drugs to be covered includes Propylthiouracil, Methimazole, Glucotrol (glipizide), Prandin (repaglinide), Avandia (rosiglitazone), Januvia (sitagliptin), Invokana (canagliflozin), Tiamoclonolone, Cymbalta (duloxetine), and Zyban (bupropion). These medications span various therapeutic classes used in endocrinology, cardiology, and mental health.

Detailed overview of selected drugs

Propylthiouracil (PTU) and Methimazole are antithyroid medications used in hyperthyroidism management. PTU inhibits thyroid hormone synthesis and prevents conversion of T4 to T3 in peripheral tissues, with the added benefit of being safe in pregnancy, although it carries a risk of hepatotoxicity. Methimazole also inhibits thyroid synthesis but is preferred for long-term therapy due to a lower risk of hepatotoxicity. Both drugs’ contraindications include hypersensitivity and pregnancy-related cautions. Common adverse reactions involve rash, joint pain, and, rarely, agranulocytosis. Nursing implications emphasize monitoring thyroid levels, signs of hypothyroidism or hyperthyroidism, and hepatic function.

Glipizide (brand name Glucotrol) and repaglinide (Prandin) are antidiabetic agents, with Glucotrol being a sulfonylurea and Prandin a meglitinide. Both stimulate insulin secretion, with Glucotrol having a longer duration of action. Indications include type 2 diabetes mellitus. Contraindications encompass sulfa allergies and diabetic ketoacidosis. Adverse effects are hypoglycemia and weight gain. Nurses must monitor blood glucose levels, educate about hypoglycemia signs, and advise consistent carbohydrate intake.

Rosiglitazone (Avandia) is a thiazolidinedione that improves insulin sensitivity by acting on PPAR-gamma receptors. Its use is associated with fluid retention and increased risk of heart failure, thus contraindicated in heart failure patients. Januvia (sitagliptin) is a DPP-4 inhibitor that enhances incretin levels, leading to increased insulin secretion and decreased glucagon production. It is generally well-tolerated but may cause pancreatitis and allergic reactions. Invokana (canagliflozin), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promotes glucosuria to lower blood glucose, but risks include urinary tract infections, dehydration, and ketoacidosis.

Tiamoclonolone denotes an anti-inflammatory agent, and Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor employed in depression and neuropathic pain management. Zyban (bupropion) is an atypical antidepressant used for smoking cessation, with potential side effects of agitation, dry mouth, and risk of seizures in predisposed individuals. Nursing implications across these medications involve monitoring efficacy, side effects, managing adverse reactions, and patient education for compliance and safety.

Conclusion

Creating comprehensive drug cards as outlined enhances nursing students’ understanding of pharmacological agents and prepares them for safe medication administration. Emphasizing the importance of accurate, detailed documentation on each card ensures that nurses can reference critical drug information promptly, reducing medication errors and optimizing patient care.

References

• Brunton, L., Hilal-Dandan, R., & Knollmann, B. (2018). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
• Golan, D. E., & Armstrong, J. (2017). Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. Lippincott Williams & Wilkins.
• Katzung, B. G., Masters, S. B., & Trevor, A. J. (2018). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill Education.
• Bennett, P. N., & Brown, M. J. (2018). Clinical Pharmacology. Churchill Livingstone.
• Chamberlain, S. (2019). Essentials of Pharmacology for Health Professions. Lippincott Williams & Wilkins.
• Lehne, R. A. (2017). Pharmacology for Nursing Care (9th ed.). Elsevier.
• Sweetman, S. C. (Ed.). (2017). Martindale: The Complete Drug Reference (38th ed.). Pharmaceutical Press.
• O'Neil, M. E., & Roberts, D. (2020). Pharmacology for Nurses. Elsevier.
• National Institute for Health and Care Excellence (NICE). (2020). Diabetes in adults: diagnosis and management. NICE Guideline.
• U.S. Food and Drug Administration (FDA). (2023). Drug Safety Communications. FDA Website.